Drug Shortage Report for MANDELAMINE
| Report ID | 2448 |
| Drug Identification Number | 00499013 |
| Brand name | MANDELAMINE |
| Common or Proper name | Methenamine Mandelate,USP |
| Company Name | SEARCHLIGHT PHARMA INC |
| Market Status | DORMANT |
| Active Ingredient(s) | Methenamine Mandelate |
| Strength(s) | 500 mg |
| Dosage form(s) | tablet |
| Route of administration | Oral |
| Packaging size | bottle |
| ATC code | J01XX |
| ATC description | OTHER ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2018-01-27 |
| Actual start date | 2018-01-27 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2019-11-07 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2017-03-14 | French | Compare |
| v1 | 2017-03-14 | English | Compare |